IG
Schedule 13G filing
Invus Global Management, LLC disclosed a 8.1% stake in CTY
Invus Global Management, LLC reported owning 8.1% of City Therapeutics, Inc. (CTY) (4,342,866 shares) in a Schedule 13G filed Oct 22, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 22, 2026
- Source
- Schedule 13G
More CTY insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.